Duffy David C.
SVP R&D and CTO at QTRX
- Sold, on record
- $2.4M
- Dollars the filings state
- Form 4 sales
- 35
- Latest Mar 23, 2022
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- QTRXQuanterix CorpSVP R&D and CTO
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale QTRXPlan not statedAug 20, 2021 2021
Sold 1,667 shares at $46.13 ($77k)
Duffy David C., SVP R&D and CTO
Sold 5.3% of holdings ($1.5M position)29,950 shares left1x usual sizeFiling
- 2 Form 4 sale QTRXPlan not statedSep 22, 2021 +33 days
Sold 1,667 shares at $47.72 ($80k)
Duffy David C., SVP R&D and CTO
Sold 5.6% of holdings ($1.4M position)28,283 shares left1x usual sizeFiling
- 3 Form 4 sale QTRXPlan not statedOct 15, 2021 +23 days
Sold 1,667 shares at $51.47 ($86k)
Duffy David C., SVP R&D and CTO
Sold 5.9% of holdings ($1.5M position)26,616 shares left1x usual sizeFiling
- 4 Form 4 sale QTRXPlan not statedNov 19, 2021 +35 days
Sold 1,667 shares at $45.54 ($76k)
Duffy David C., SVP R&D and CTO
Sold 6.3% of holdings ($1.2M position)24,949 shares left1x usual sizeFiling
- 5 Form 4 sale QTRXPlan not statedDec 29, 2021 +40 days
Sold 1,667 shares at $40.71 ($68k)
Duffy David C., SVP R&D and CTO
Sold 6.7% of holdings ($1M position)23,282 shares left1x usual sizeFiling
- 6 Form 4 sale QTRXPlan not statedJan 31, 2022 +33 days
Sold 3,266 shares at $30.00 ($98k)
Duffy David C., SVP R&D and CTO
Sold 5.1% of holdings ($1.9M position)61,262 shares left2x usual sizeFiling
- 7 Form 4 sale QTRXPlan not statedFeb 4, 2022 +4 days
Sold 3,266 shares at $30.91 ($101k)
Duffy David C., SVP R&D and CTO
Sold 5.3% of holdings ($1.9M position)57,996 shares left2x usual sizeFiling
- 8 Form 4 sale QTRXPlan not statedMar 23, 2022 +47 days
Sold 3,266 shares at $30.00 ($98k)
Duffy David C., SVP R&D and CTO
Sold 5.6% of holdings ($1.7M position)54,730 shares left2x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (35)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 23, 2022 | Mar 28, 2022 | QTRX | SVP R&D and CTO | Form 4 sale | 3,266 | $98k | 5.6% | Plan not stated | SEC |
| Feb 4, 2022 | Feb 4, 2022 | QTRX | SVP R&D and CTO | Form 4 sale | 3,266 | $101k | 5.3% | Plan not stated | SEC |
| Jan 31, 2022 | Jan 31, 2022 | QTRX | SVP R&D and CTO | Form 4 sale | 3,266 | $98k | 5.1% | Plan not stated | SEC |
| Dec 29, 2021 | Dec 30, 2021 | QTRX | SVP R&D and CTO | Form 4 sale | 1,667 | $68k | 6.7% | Plan not stated | SEC |
| Nov 19, 2021 | Nov 22, 2021 | QTRX | SVP R&D and CTO | Form 4 sale | 1,667 | $76k | 6.3% | Plan not stated | SEC |
| Oct 15, 2021 | Oct 19, 2021 | QTRX | SVP R&D and CTO | Form 4 sale | 1,667 | $86k | 5.9% | Plan not stated | SEC |
| Sep 22, 2021 | Oct 4, 2021 | QTRX | SVP R&D and CTO | Form 4 sale | 1,667 | $80k | 5.6% | Plan not stated | SEC |
| Aug 20, 2021 | Aug 20, 2021 | QTRX | SVP R&D and CTO | Form 4 sale | 1,667 | $77k | 5.3% | Plan not stated | SEC |
| Jul 14, 2021 | Jul 14, 2021 | QTRX | SVP R&D and CTO | Form 4 sale | 1,667 | $96k | 5.0% | Plan not stated | SEC |
| Jun 23, 2021 | Jun 23, 2021 | QTRX | SVP R&D and CTO | Form 4 sale | 1,667 | $104k | 4.8% | Plan not stated | SEC |
| May 28, 2021 | Jun 2, 2021 | QTRX | SVP R&D and CTO | Form 4 sale | 1,667 | $85k | 4.6% | Plan not stated | SEC |
| Apr 15, 2021 | Apr 15, 2021 | QTRX | SVP R&D and CTO | Form 4 sale | 1,667 | $104k | 4.4% | Plan not stated | SEC |
| Mar 19, 2021 | Mar 19, 2021 | QTRX | SVP R&D and CTO | Form 4 sale | 1,667 | $97k | 4.2% | Plan not stated | SEC |
| Feb 11, 2021 | Feb 12, 2021 | QTRX | SVP R&D and CTO | Form 4 sale | 1,667 | $133k | 4.0% | Plan not stated | SEC |
| Jan 22, 2021 | Jan 22, 2021 | QTRX | SVP R&D and CTO | Form 4 sale | 1,667 | $132k | 4.1% | Plan not stated | SEC |
| Dec 18, 2020 | Dec 21, 2020 | QTRX | SVP R&D and CTO | Form 4 sale | 1,667 | $73k | 3.9% | Plan not stated | SEC |
| Nov 12, 2020 | Nov 16, 2020 | QTRX | SVP R&D and CTO | Form 4 sale | 1,667 | $82k | 3.9% | Plan not stated | SEC |
| Oct 16, 2020 | Oct 20, 2020 | QTRX | SVP R&D and CTO | Form 4 sale | 1,667 | $72k | 3.7% | Plan not stated | SEC |
| Sep 17, 2020 | Sep 17, 2020 | QTRX | SVP R&D and CTO | Form 4 sale | 1,667 | $54k | 3.6% | Plan not stated | SEC |
| Aug 19, 2020 | Aug 20, 2020 | QTRX | SVP R&D and CTO | Form 4 sale | 1,680 | $59k | 3.5% | Plan not stated | SEC |
| Jul 13, 2020 | Jul 14, 2020 | QTRX | SVP R&D and CTO | Form 4 sale | 1,667 | $46k | 3.4% | Plan not stated | SEC |
| Jun 16, 2020 | Jun 18, 2020 | QTRX | SVP R&D and CTO | Form 4 sale | 1,667 | $44k | 3.3% | Plan not stated | SEC |
| May 8, 2020 | May 12, 2020 | QTRX | SVP R&D and CTO | Form 4 sale | 1,667 | $44k | 3.2% | Plan not stated | SEC |
| Apr 15, 2020 | Apr 17, 2020 | QTRX | SVP R&D and CTO | Form 4 sale | 1,667 | $35k | 3.1% | Plan not stated | SEC |
| Mar 19, 2020 | Mar 20, 2020 | QTRX | SVP R&D and CTO | Form 4 sale | 1,667 | $19k | 3.0% | Plan not stated | SEC |
| Feb 11, 2020 | Feb 11, 2020 | QTRX | SVP R&D and CTO | Form 4 sale | 1,667 | $46k | 3.2% | Plan not stated | SEC |
| Jan 17, 2020 | Jan 17, 2020 | QTRX | SVP R&D and CTO | Form 4 sale | 1,941 | $47k | 3.6% | Plan not stated | SEC |
| Dec 16, 2019 | Dec 16, 2019 | QTRX | SVP R&D and CTO | Form 4 sale | 1,667 | $40k | 3.6% | Plan not stated | SEC |
| Nov 18, 2019 | Nov 19, 2019 | QTRX | SVP R&D and CTO | Form 4 sale | 1,667 | $38k | 3.6% | Plan not stated | SEC |
| Oct 21, 2019 | Oct 21, 2019 | QTRX | SVP R&D and CTO | Form 4 sale | 1,667 | $34k | 3.6% | Plan not stated | SEC |
| Sep 16, 2019 | Sep 17, 2019 | QTRX | SVP R&D and CTO | Form 4 sale | 1,667 | $43k | 3.6% | Plan not stated | SEC |
| Aug 19, 2019 | Aug 20, 2019 | QTRX | SVP R&D and CTO | Form 4 sale | 1,667 | $47k | 3.6% | Plan not stated | SEC |
| Jul 15, 2019 | Jul 15, 2019 | QTRX | SVP R&D and CTO | Form 4 sale | 1,667 | $49k | 3.6% | Plan not stated | SEC |
| Jun 17, 2019 | Jun 17, 2019 | QTRX | SVP R&D and CTO | Form 4 sale | 1,667 | $55k | 3.6% | Plan not stated | SEC |
| May 15, 2019 | May 15, 2019 | QTRX | SVP R&D and CTO | Form 4 sale | 1,277 | $27k | 2.8% | Plan not stated | SEC |